Celltrion
068270.KS
#738
Rank
NZ$47.61 B
Marketcap
$221.25
Share price
-0.55%
Change (1 day)
-1.58%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.92

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $5.30. In 2022 the company made an earnings per share (EPS) of $5.16 a decrease over its 2021 EPS that were of $6.13.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.92-4.7%
2022$5.16-15.84%
2021$6.1312.77%
2020$5.4470.79%
2019$3.1815.63%
2018$2.75-33.13%
2017$4.12141.17%
2016$1.718.28%
2015$1.5811.28%
2014$1.4216.37%
2013$1.22-67.42%
2012$3.7484.22%
2011$2.0362.13%
2010$1.2580.61%
2009$0.69-559.63%
2008-$0.15-123.16%
2007$0.65